RxDoctor Payments DataLook up a doctor →

Edward Kim, MD

Vascular & Interventional Radiology · New York, NYNPI 1851565543

Payments from drug & device makers

$855,503in general payments, 2019–2025

Across 770 payments — averaging $1111.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$633K
  • Siemens Medical Solutions USA, Inc.$41K
  • Philips North America LLC$32K
  • Biocompatibles, Inc.$27K
  • Medical Device Business Services, Inc.$18K
  • AstraZeneca$17K
  • plus $88K from 26 others
$2,903in research payments, 2019–2025

Across 11 payments — averaging $263.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$2K
  • Novartis$1K

What the payments were for

  • Consulting fees$318,45938%
  • Speaking & faculty fees$418,28750%
  • Grants$1,8000%
  • Travel & lodging$64,5378%
  • Food & beverage$27,6753%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$855,503 in reported general payments places this provider in the 95th percentile of 306 vascular & interventional radiology providers in New York.

See all vascular & interventional radiology providers in New York

Medicare billing

Part B allowed, 2024
$63,303
Medicare patients
68
Services billed
400

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen27$98

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →